TY  - GEN
AU  - Chang,Chih-Chuan
AU  - Liang,Yu-Chuan
AU  - Klutz,Athena
AU  - Hsu,Chuan-I
AU  - Lin,Chien-Fu
AU  - Mold,David E
AU  - Chou,Ting-Chao
AU  - Lee,Yuan Chuan
AU  - Huang,Ru Chih C
TI  - Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel
SN  - 0344-5704
PY  - 2006///1016
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - antagonists & inhibitors
KW  - Animals
KW  - Antineoplastic Agents, Phytogenic
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Blotting, Western
KW  - Breast Neoplasms
KW  - genetics
KW  - Cell Line, Tumor
KW  - Dose-Response Relationship, Drug
KW  - Doxorubicin
KW  - administration & dosage
KW  - Drug Resistance, Multiple
KW  - drug effects
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression
KW  - Humans
KW  - Masoprocol
KW  - Mice
KW  - Mice, Nude
KW  - Monosaccharides
KW  - Paclitaxel
KW  - RNA, Messenger
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Xenograft Model Antitumor Assays
KW  - methods
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-006-0214-9
ER  -